Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 8 studies | 38% ± 11% | |
macrophage | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of KCNK13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 211.20 | 652 / 653 | 95% | 11.08 | 573 / 605 |
kidney | 99% | 188.27 | 88 / 89 | 79% | 2.95 | 716 / 901 |
brain | 81% | 77.82 | 2129 / 2642 | 91% | 4.95 | 644 / 705 |
adrenal gland | 85% | 47.49 | 219 / 258 | 65% | 4.41 | 149 / 230 |
lung | 77% | 51.95 | 445 / 578 | 71% | 2.30 | 820 / 1155 |
breast | 57% | 27.49 | 263 / 459 | 84% | 3.21 | 938 / 1118 |
bladder | 52% | 17.67 | 11 / 21 | 52% | 2.79 | 261 / 504 |
prostate | 57% | 19.12 | 140 / 245 | 41% | 1.00 | 204 / 502 |
spleen | 92% | 72.47 | 221 / 241 | 0% | 0 | 0 / 0 |
ovary | 18% | 5.03 | 33 / 180 | 67% | 2.64 | 290 / 430 |
intestine | 45% | 18.99 | 436 / 966 | 39% | 0.85 | 208 / 527 |
pancreas | 22% | 7.48 | 71 / 328 | 60% | 1.58 | 106 / 178 |
heart | 80% | 107.37 | 692 / 861 | 0% | 0 | 0 / 0 |
stomach | 25% | 6.76 | 91 / 359 | 50% | 1.06 | 143 / 286 |
peripheral blood | 74% | 71.40 | 686 / 929 | 0% | 0 | 0 / 0 |
uterus | 15% | 4.63 | 26 / 170 | 57% | 1.97 | 260 / 459 |
tonsil | 0% | 0 | 0 / 0 | 71% | 1.87 | 32 / 45 |
skin | 14% | 3.46 | 255 / 1809 | 52% | 1.48 | 245 / 472 |
liver | 31% | 13.38 | 71 / 226 | 33% | 1.39 | 133 / 406 |
lymph node | 0% | 0 | 0 / 0 | 59% | 1.73 | 17 / 29 |
adipose | 57% | 31.92 | 683 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 20% | 5.90 | 295 / 1445 | 33% | 0.69 | 60 / 183 |
blood vessel | 41% | 19.68 | 554 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 9% | 0.11 | 7 / 80 |
muscle | 2% | 0.80 | 15 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030322 | Biological process | stabilization of membrane potential |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0034702 | Cellular component | monoatomic ion channel complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0022841 | Molecular function | potassium ion leak channel activity |
GO_0015271 | Molecular function | outward rectifier potassium channel activity |
Gene name | KCNK13 |
Protein name | Potassium channel subfamily K member 13 (Tandem pore domain halothane-inhibited potassium channel 1) (THIK-1) |
Synonyms | |
Description | FUNCTION: Potassium channel displaying weak inward rectification in symmetrical K(+) solution. . |
Accessions | ENST00000282146.5 Q9HB14 |